MicroVision, Inc.

As of May 9, 2023, MicroVision, Inc. is considered risky and overvalued, with concerning financial ratios and a significant long-term stock performance decline of -69.95% compared to the S&P 500's 70.41% gain.

As of May 9, 2023, MicroVision, Inc. is rated as risky and overvalued, with concerning financial metrics and a year-to-date stock performance of -13.74%, significantly underperforming the S&P 500's 2.44% return.

As of June 5, 2025, the market trend has shifted to mildly bearish, indicated by weekly MACD and Bollinger Bands, despite some monthly indicators showing mild bullishness.

As of March 2022, the management team of MicroVision, Inc. includes CEO Sumit Sharma, Independent Chairman Brian Turner, and directors Judy Curran, Yalon Farhi, Mark Spitzer, Simon Biddiscombe, and Robert Carlile, combining executive leadership with independent governance.

MicroVision, Inc. develops laser beam scanning technology and operates in the Other Electrical Equipment industry. As of March 2025, it reported net sales of $1 million and a net loss of $29 million, with a market cap of $314.07 million.

As of Jun 18, MicroVision, Inc. has a market capitalization of 314.07 million, with net sales of 4.33 million and a net profit of -99.39 million over the last four quarters. Shareholder's funds are 48.77 million, and total assets are 121.16 million.